Litigation

Abbott Withdraws Diet Pill Meridia In United States, Canada

WASHINGTON, D.C. — (AP) Abbott Laboratories said Friday it will withdraw its diet pill Meridia in the U.S. and Canada, after coming under pressure from health regulators who say the drug increases the risk of heart attack and stroke in patients with a history of heart disease. Companies have struggled for decades. . . . Full version available to lexis.com subscribers.